SCHEMBL4277672

SCHEMBL4277672

COc1ccc(-c2nc(CCC(=O)c3ccccc3C)co2)cc1OCC1CC1

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 10/20 0.41
PDE4A P27815 7/20 0.40
PTGS2 P35354 1/20 0.40
FPR2 P25090 1/20 0.40
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284472 0.93 PDE4B (0.42) PDE4BPDE4AFPR2PDE4CPDE4D
SCHEMBL4271315 0.91 FPR2 (0.40) PDE4BPDE4AFPR2PDE4CPDE4D
SCHEMBL34465343 0.91 PDE4A (0.41) PDE4BPDE4APTGS2FPR2PDE4C
SCHEMBL4279551 0.91 PDE4A (0.41) PDE4BPDE4APTGS2FPR2PDE4C
SCHEMBL4275689 0.90 PDE4B (0.40) PDE4BPDE4AFPR2PDE4CPDE4D
SCHEMBL29813509 0.90 PDE4B (0.40) PDE4BPDE4AFPR2PDE4CPDE4D
SCHEMBL13701429 0.89 PTGS2 (0.48) PTGS2MAPT
SCHEMBL4273527 0.88 PDE4B (0.43) PDE4BPDE4AFPR2PDE4CPDE4D
SCHEMBL34465347 0.88 PDE4B (0.39) PDE4BPDE4AFPR2PDE4CPDE4D
SCHEMBL4280402 0.88 PDE4B (0.39) PDE4BPDE4AFPR2PDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICALC., LTD. (JP) 2026-04-23 US disclosed
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-05-09 US disclosed
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-08-25 US disclosed
US-20200078340-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-03-12 US disclosed
US-20190070151-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-03-07 US disclosed
US-RE46792-E1 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-04-17 US disclosed
US-20170216260-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-08-03 US disclosed
EP-2890686-B1 METHOD FOR PRODUCING OXAZOLE COMPOUND OTSUKA PHARMA CO LTD (JP) 2017-01-04 EP disclosed
US-9181205-B2 Method for producing oxazole compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
US-9181205-B2 Method for producing oxazole compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
US-20150239855-A1 Method for Producing Oxazole Compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-08-27 US disclosed
US-20150239855-A1 Method for Producing Oxazole Compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-08-27 US disclosed
EP-1954684-B1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMA CO LTD (JP) 2014-05-07 EP disclosed
US-20140100226-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-04-10 US disclosed
WO-2014034958-A1 METHOD FOR PRODUCING OXAZOLE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-03-06 WO disclosed
US-8637559-B2 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-01-28 US disclosed
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216260-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 5/4885PDE4A 2/4885PTGS2 356/4885
US-20140100226-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 5/4885PDE4A 2/4885PTGS2 356/4885
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 5/4885PDE4A 2/4885PTGS2 356/4885
US-20150239855-A1 Method for Producing Oxazole Compound OXA1L, CYB5R3, CBR3 PDE4B 2566/4885PDE4A 3471/4885PTGS2 1429/4885
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE7B, PDE4B, PDE1B PDE4B 2/4885PDE4A 10/4885PTGS2 642/4885
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 5/4885PDE4A 2/4885PTGS2 356/4885
US-20200078340-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 5/4885PDE4A 2/4885PTGS2 356/4885
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 4/4885PDE4A 2/4885PTGS2 301/4885
US-20190070151-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A PDE4B 5/4885PDE4A 2/4885PTGS2 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.